We studied the psychological performance and the quality of life in patients with differentiated thyroid carcinoma, either during treatment with chronic suppressive doses of levothyroxine, or during the withdrawal of levothyroxine needed to perform whole-body scanning with radioactive iodine, with those of appropriate healthy controls. Eighteen women with differentiated thyroid carcinoma and 18 euthyroid age-matched healthy women were recruited. Patients were studied the day before levothyroxine withdrawal (when in chronic mild or subclinical hyperthyroidism), 4-7 days later (when most patients had normal serum free thyroxine and free triiodothyronine levels), and the day before scanning (when in profound hypothyroidism). Controls were studied at one time point. When compared with controls, patients presented with impairment of several indexes during chronic suppressive levothyroxine therapy (total score, emotional, sleep, energy and social of the Nottingham Health Profile; mental health, general health and social function of the SF-36, and total score on Wais Digit Span; P<0.05 for all comparisons). Also, quality of life indexes (19 of 21 scores), cognitive tests (6 of 12 scores), and affective and physical symptoms visual mental scales (18 of 19) worsened during profound hypothyroidism (P<0.05 for all comparisons). Quality of life and cognitive performance were almost comparable with those of euthyroid controls when most patients had normal free thyroxine and triiodothyronine levels. In conclusion, quality of life and psychometric functionality in patients with differentiated thyroid carcinoma is not only affected by withdrawal of levothyroxine but also by long-term treatment with supraphysiological doses of levothyroxine.

This article has been cited by other articles:

				M. H. Samuels, K. G. Schuff, N. E. Carlson, P. Carello, and J. S. Janowsky Health Status, Mood, and Cognition in Experimentally Induced Subclinical Thyrotoxicosis J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1730 - 1736. [Abstract] [Full Text] [PDF]

				B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]

				J. I Botella-Carretero, F. Alvarez-Blasco, J. L. S. Millan, and H. F Escobar-Morreale Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women Eur. J. Endocrinol., May 1, 2007; 156(5): 539 - 545. [Abstract] [Full Text] [PDF]

				L. H Duntas and B. Biondi Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences Eur. J. Endocrinol., January 1, 2007; 156(1): 13 - 19. [Abstract] [Full Text] [PDF]

				J. de Groot, T. Links, and W. van der Graaf Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine Ann. Onc., November 1, 2006; 17(11): 1719 - 1720. [Full Text] [PDF]

				P. R. Schroeder, B. R. Haugen, F. Pacini, C. Reiners, M. Schlumberger, S. I. Sherman, D. S. Cooper, K. G. Schuff, L. E. Braverman, M. C. Skarulis, et al. A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone Withdrawal J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 878 - 884. [Abstract] [Full Text] [PDF]

				J. I Botella-Carretero, A. Prados, L. Manzano, M. T Montero, L. Escribano, J. Sancho, and H. F Escobar-Morreale The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal Eur. J. Endocrinol., August 1, 2005; 153(2): 223 - 230. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, J. I. Botella-Carretero, F. E. del Rey, and G. M. de Escobar Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4946 - 4954. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, J. I. Botella-Carretero, M. Gomez-Bueno, J. M. Galan, V. Barrios, and J. Sancho Thyroid Hormone Replacement Therapy in Primary Hypothyroidism: A Randomized Trial Comparing L-Thyroxine plus Liothyronine with L-Thyroxine Alone Ann Intern Med, March 15, 2005; 142(6): 412 - 424. [Abstract] [Full Text] [PDF]